30 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
.
[Reserved]
Item 16A.
Audit Committee Financial Expert
Item 16B.
Code of Ethics
Item 16C.
Principal Accountant Fees and Services
Item 16D.
Exemptions from … , ChemDiv. Inc. and Chief Business Officer, Expert Systems Inc. since December 2023 and current Director, Globestar Therapeutics Corporation since April
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
.
[Reserved]
Item 16A.
Audit Committee Financial Expert
Item 16B.
Code of Ethics
Item 16C.
Principal Accountant Fees and Services
Item 16D.
Exemptions from … , ChemDiv. Inc. and Chief Business Officer, Expert Systems Inc. since December 2023 and current Director, Globestar Therapeutics Corporation since
6-K
EX-99.2
XRTX
XORTX Therapeutics Inc
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
committee financial expert” as such term is defined by the U.S. Securities and Exchange Commission.
Definition of Financial Literacy. “Financially
6-K
EX-99.3
dp38o9aqp17p 0v0
3 Apr 23
Consolidated Financial Statements
6:05am
424B4
ymyfkuqqg3i
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
2mcmmdno4l
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
mcf9rpb6vt5i oim
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
755hl4vau 6ylhyto
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
or8orl
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
n492omkwh
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
6-K
EX-99.1
kg39hklim0qyc42xdx6
6 Jun 22
XORTX Welcomes New Member to the Board of Directors and Appoints Chair
7:00am
20-F
h6h70 qbeen7
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.27
iv58fnbr u95y
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-15.2
qrd07
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
ulc8a8w ar
13 Apr 22
Current report (foreign)
7:23am
6-K
EX-99.2
hww51a
23 Nov 21
Notice of Annual & Special Meeting of Shareholders
7:17am